Torches Suppression Masse dmmr colon cancer distillation aérien Intégrer
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
High Response Rate With Neoadjuvant Anti-PD-1 in Localized dMMR Colorectal Cancer | MedPage Today
Immunotherapy in colorectal cancer: current achievements and future perspective
An example of early-stage dMMR type 2 colorectal cancer stained with... | Download Scientific Diagram
Frontiers | Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines
Final KEYNOTE 177 overall survival data for MSI-H/dMMR metastatic colorectal cancer - Onco Americas
Understanding MSI-High and DNA Mismatch Repair - CancerConnect
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy
Molecular strategy to distinguish LS-related from sporadic MSI/dMMR... | Download Scientific Diagram
Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm
Cancer du côlon dMMR : changement de paradigme
MSI-H Biomarker | Colorectal Cancer Alliance
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)
ESMO | Press Release | preoperative immunotherapy colon cancer
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. - Abstract - Europe PMC
In patients with dMMR or MSI-H-positive tumors, multiple mutations... | Download Scientific Diagram
Current Oncology | Free Full-Text | Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
Purpose
Final Results Support Pembrolizumab as Standard of Care in MSI-H/dMMR Metastatic Colorectal Cancer - Cancer Therapy Advisor
Cancers | Free Full-Text | Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer: The NICHE-2 study - YouTube
VisualAbstract: Pembrolizumab linked to longer cancer-free period in advanced MSI-H-dMMR colorectal cancer | 2 Minute Medicine